VAXESS

April 4, 2014

Thomas Monath and Russell Middaugh Join Scientific Advisory Board of Vaxess Technologies

Vaxess Technologies, Inc., an innovative life sciences company developing a novel silk protein-based vaccine stabilization technology, announced
today that Thomas Monath and Russell Middaugh have joined the company’s scientific advisory board.

Press Release – Thomas Monath and Russell Middaugh Join Scientific Advisory Board of Vaxess Technologies

FierceVaccines